BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15684817)

  • 41. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
    Desai SD; Li TK; Rodriguez-Bauman A; Rubin EH; Liu LF
    Cancer Res; 2001 Aug; 61(15):5926-32. PubMed ID: 11479235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.
    Pitha-Rowe IF; Pitha PM
    Cytokine Growth Factor Rev; 2007; 18(5-6):409-17. PubMed ID: 17689132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity.
    Takeuchi T; Yokosawa H
    Biochem Biophys Res Commun; 2005 Oct; 336(1):9-13. PubMed ID: 16112642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Pathways of Interferon-Stimulated Gene 15: Implications in Cancer.
    Tecalco-Cruz AC
    Curr Protein Pept Sci; 2021; 22(1):19-28. PubMed ID: 33292152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.
    Zuo C; Sheng X; Ma M; Xia M; Ouyang L
    Oncotarget; 2016 Nov; 7(45):74393-74409. PubMed ID: 27626310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ISG15 and immune diseases.
    Jeon YJ; Yoo HM; Chung CH
    Biochim Biophys Acta; 2010 May; 1802(5):485-96. PubMed ID: 20153823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance.
    Desai SD; Mao Y; Sun M; Li TK; Wu J; Liu LF
    Ann N Y Acad Sci; 2000; 922():306-8. PubMed ID: 11193908
    [No Abstract]   [Full Text] [Related]  

  • 48. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.
    Wong JJ; Pung YF; Sze NS; Chin KC
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10735-40. PubMed ID: 16815975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species.
    Deaton MK; Dzimianski JV; Daczkowski CM; Whitney GK; Mank NJ; Parham MM; Bergeron E; Pegan SD
    J Virol; 2016 Sep; 90(18):8314-27. PubMed ID: 27412597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenomic identification of targets for adjuvant therapy with the topoisomerase poison camptothecin.
    Carson JP; Zhang N; Frampton GM; Gerry NP; Lenburg ME; Christman MF
    Cancer Res; 2004 Mar; 64(6):2096-104. PubMed ID: 15026349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diverse repertoire of ISG15: more intricate than initially thought.
    Kang JA; Kim YJ; Jeon YJ
    Exp Mol Med; 2022 Nov; 54(11):1779-1792. PubMed ID: 36319753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. mHERC6 is the essential ISG15 E3 ligase in the murine system.
    Ketscher L; Basters A; Prinz M; Knobeloch KP
    Biochem Biophys Res Commun; 2012 Jan; 417(1):135-40. PubMed ID: 22138649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog.
    Hamerman JA; Hayashi F; Schroeder LA; Gygi SP; Haas AL; Hampson L; Coughlin P; Aebersold R; Aderem A
    J Immunol; 2002 Mar; 168(5):2415-23. PubMed ID: 11859133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zebrafish ISG15 exerts a strong antiviral activity against RNA and DNA viruses and regulates the interferon response.
    Langevin C; van der Aa LM; Houel A; Torhy C; Briolat V; Lunazzi A; Harmache A; Bremont M; Levraud JP; Boudinot P
    J Virol; 2013 Sep; 87(18):10025-36. PubMed ID: 23824820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Approaches for investigating the extracellular signaling function of ISG15.
    Swaim CD; Canadeo LA; Huibregtse JM
    Methods Enzymol; 2019; 618():211-227. PubMed ID: 30850053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
    Jeon YJ; Jo MG; Yoo HM; Hong SH; Park JM; Ka SH; Oh KH; Seol JH; Jung YK; Chung CH
    J Clin Invest; 2012 Jul; 122(7):2622-36. PubMed ID: 22706304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin.
    Zou W; Papov V; Malakhova O; Kim KI; Dao C; Li J; Zhang DE
    Biochem Biophys Res Commun; 2005 Oct; 336(1):61-8. PubMed ID: 16122702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.
    Dastur A; Beaudenon S; Kelley M; Krug RM; Huibregtse JM
    J Biol Chem; 2006 Feb; 281(7):4334-8. PubMed ID: 16407192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo functions of isgylation.
    Knobeloch KP
    Subcell Biochem; 2010; 54():215-27. PubMed ID: 21222285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ISG15, not just another ubiquitin-like protein.
    Kim KI; Zhang DE
    Biochem Biophys Res Commun; 2003 Aug; 307(3):431-4. PubMed ID: 12893238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.